Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

Published:2001-05 Issue:10 Volume:8 Page:746-759
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Nemunaitis J,Cunningham C,Buchanan A,Blackburn A,Edelman G,Maples P,Netto G,Tong A,Randlev B,Olson S,Kirn D

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301424.pdf

Reference91 articles.

1. Kozarsky K, Grossman M, Wilson JM . Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia Somat Cell Mol Genet 1993 19: 449–458

2. Roth JA, Cristiano RJ . Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 1997 89: 21–39

3. Martuza RL et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant Science 1991 252: 854–856

4. Kirn D . Replication-selective micro-organisms: fighting cancer with targeted germ warfare J Clin Invest 2000 105: 836–838

5. Heise C, Kirn D . Replication-selective adenoviruses for cancer J Clin Invest 2000 105: 847–851

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner;Biomarker Research;2024-03-25

2. An oncolytic virus–T cell chimera for cancer immunotherapy;Nature Biotechnology;2024-02-09

3. Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives;Current Issues in Molecular Biology;2023-11-16

4. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05

5. Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors;Journal for ImmunoTherapy of Cancer;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3